The conference call for the period ending June 30, 2026 for MidCap Financial Investment Corporation. At this time, all participants have been placed in a listen-only mode. The call will be open for a question and answer session following the speaker's prepared remarks. If you would like to ask a question at that time, simply press star 1 on your telephone keypad. If you would like to withdraw your question, press star 2. I will now turn the call over to Elizabeth Besen, Investor Relations Manager for MidCap Financial Investment Corporation.

Thank you, Operator, and thank you everyone for joining us today. We appreciate your interest in MidCap Financial Investment Corporation. Speaking on today's call are Tanner Powell, Chief Executive Officer I'd like to advise everyone that today's call and webcast are being recorded. Please note that they are properties of MidCat Financial Investment Corporation and that any unauthorized broadcast in any form is strictly prohibited. Information about the audio replay of this call is available in our press release. I'd also like to call your attention to the customary Steve Parker disclosure in our press release regarding forward-looking information. Today's conference call and webcast may include forward-looking statements. You should refer not undertake to update our forward-looking statements or projections unless required by law. To obtain copies of our SEC filings, please visit either the SEC's website at www.sec.gov or our website at www.midcapfinancialic.com. I'd also like to remind everyone that we've posted a supplemental financial information package on our website so you can see information about the portfolio as well as the company's financial performance. Thank you, Elizabeth. Good morning, everyone. Thank you for joining for MidCap Financial Investment Corporation's quarterly earnings commerce call. Early this morning, we issued our press release.

and filed our Form 10-Q for the period ended June 30th, 2026. I'll dig into today's call with an overview of NFIC's second quarter results and investment activity. Following that, I'll hand the call over to Ted, who will walk through our investment activity in detail and provide a portfolio update. Kenny will then review our financial results in detail. Beginning with an overview of our results, net investment income per share for the quarter was $0.40, while gap net loss per share was $0.21. Net value per share at the end of June was $13.37. represented a 3.2% decline from the prior quarter. The $0.45 decrease in NAV was driven by a net loss of $0.61 on the portfolio, which was partially offset by net investment income exceeding the dividend by $0.09, plus approximately $0.07 of accretion from stock repurchases executed below NAV. The quarter reflected some credit pressure within the portfolio, with a net loss of $50.3 million, or $0.61 per share, concentrated among a limited number of positions. Ted will address the largest negative contributors shortly. MFIC new commitments were intentionally modest at $5.8 million for the quarter to support three existing borrowers. Net repayments were $160 million in aggregate. As a result of the net loss, since stock buyback activity, MFIC's net leverage declined only modestly to 1.54 times at quarter end. Excluding stock buybacks made during the quarter, MFIC's net leverage would have declined to 1.5 times at quarter end. Looking ahead, we will make capital allocation decisions based on leverage and market conditions. At the end of June, MFIC's investment in Merck's totaled approximately $68.6 million in fair value, representing 2.5% of our portfolio. This reflects a $12.5 million pay down during the June quarter from the sale of one aircraft in a joint venture plus a modest rental. As a reminder, Merck's earns income from its servicing activities for Navigator, Apollo's dedicated aircraft leasing facility. Having fully deployed executive commitments, Navigator is in the hardest period, and as such, the fund is opportunistically monetizing assets to optimize fund-level returns. Merckx receives a remarketing fee on each aircraft. Subsequent to quarter end, Merckx has sold one aircraft and is in the process of closing on the sale of an engine. Navigator is in the process of selling a large portfolio of aircraft, which will generate servicing income for Merckx. We expect to receive additional payouts from Merckx in the September quarter from these transactions. Turning back to the stock repurchases as discussed on last quarter's call in April, we purchased 31.9 million of stock through our 10B51 trading plan, fully utilizing our authorization. Given our focus on reducing MFIC's leverage, we are currently prioritizing capital allocation towards that objective rather than towards additional stock repurchases. Moving on to the dividend, on August 5th, 2026, our Board of Directors declared a quarterly dividend of $0.31 per share for stockholders who record as of September 8th, 2026, payable on September 24th, 2026. With that, I will now turn the call over to Ted.

Thank you, Tanner. Good morning, everyone. I will summarize our investment activity for the quarter and then provide some details on our investment portfolio. As Tanner noted, MFIC's new commitments in the second quarter were $5.8 million, all in support of three existing borrowers. In aggregate, net repayments for the quarter totaled $160 million. Shifting to our investment portfolio, at the end of June, our portfolio had a fair value of $2.77 billion and was invested in 229 companies across 45 different industries. Direct Origination and other represented 97% of the portfolio. Merge represented approximately 2.5% of the portfolio. And liquid positions from our mergers with two funds in 2024 totaled approximately 1%. All of these figures are on a fair value basis. Specific to the direct origination portfolio, at the end of June, 97% was first lien and 95% was backed by financial sponsors, both on a fair value basis. The average funded position was $12.1 million. The median EBITDA was approximately $53 million. Approximately 94% had one or more financial covenants on a cost basis. The weighted average yield at cost of our direct origination portfolio was 9.5% on average for the June quarter, compared to 9.6% in the prior quarter. At the end of June, the weighted average spread on the directly originated corporate lending portfolio was 539 basis points, of one basis point compared to the end of March. Regarding software, our exposure was essentially flat quarter-over-quarter in dollar terms. As of June 30, 2026, software exposure represented just 11.9% of MFIC's portfolio at fair value, which is well below the BDC industry average. You can find additional details on our software exposure on page 5 of the earnings supplement. As Tanner mentioned, the portfolio generated a net loss of $50.3 million, driven by credit-related weakness concentrated in a limited number of positions. Five names contributed approximately 80% of the net loss. I will now provide some color on the largest contributors. Starting with Chiron Ego, a company that provides workflow technology for graphics creation and real-time data visualization for news and sports productions. During the quarter, MFIC completed a debt-for-equity exchange, converting $60 million of term debt into preferred equity and reducing the commitment on the revolver. A contraction in market multiples and a decline in EBITDA drove the value of the preferred equity lower, resulting in a $21.5 million net loss for the quarter. The next four contributors to the net loss include Midwest Vision Partners, New Era Technology, American Restoration, and Thomas Scientific, each of which is experiencing EBITDA pressure and rising leverage. We at MidCap remain proactive in managing these underperforming credits. Turning to overall credit quality, no investments were placed on non-accrual status during the quarter, and two investments were restructured and restored to accrual status. At the end, at the quarter end, investments on non-recrual status totaled $77.6 million, representing 2.8% of total portfolio at fair value. Borrower net leverage, or debt to EBITDA, increased 5.36 times from 5.29 times at the end of March, while the weighted average interest coverage ratio remained 2.3 times. Borrower wall regularization was roughly flat quarter over quarter. Pick income represents 6.2% of total investment income for this June quarter. With that, I will now turn the call over to Teddy to discuss our financial results in detail.

Thank you, Ted, and good morning, everyone. I will begin by reviewing certain key financial information for the quarter, followed by a review of our capital position. Total investment income for the June quarter was approximately $68.2 million, a decline of $3.6 million percent. The decrease was primarily driven by lower interest income resulting from a decrease in the size of the portfolio. The previous dividend income was approximately $2.7 million, and the B income was approximately $600,000, both flat compared to the prior quarter. Dividend income was approximately $200,000. Net expenses for the quarter were $35.5 million, a decline of $2.1 million, or 5.6% from the prior quarter. The decrease was driven primarily by lower interest expenses resulting from the lower average debt balance, as well as lower management fees and administrative service expenses. The portfolio had a net loss of approximately $50.3 million, or 61 cents per share, which eliminated the incentive fee again this quarter. The June quarter, net investment income per share was $0.40, while GAAP net loss was $0.21. Turning to the balance sheet, at the end of June, the portfolio had a fair value of $2.77 billion. Total principal debt outstanding was $1.74 billion, and total net assets total $1.1 billion, or $13.37 per share. The company ended the quarter at 1.54 times net leverage. As discussed on last quarter's call, during the June quarter, we repurchased approximately 2.76 million shares at an average price of $11.58, inclusive of commissions, for a total cost of $31.9 million. As Tanner mentioned, we are currently prioritizing capital allocation towards reducing leverage rather than stock repurchases. Our cost of debt for the quarter increased slightly to 5.66% up from 5.61% in the prior quarter. Post quarter end, we refinanced $125 million of 4.5% notes that matured in July with our revolving credit facility. At today's base rates, the revolving credit facility carried a higher cost relative to the notes, which is expected to modestly increase our cost of debt. The fixed liquidity position remains sound with sufficient access to capital under a revolving credit facility. As of the end of the quarter, the ongoing capacity under the revolving credit facility was $925 million. Justin, for the recent maturity of the 2026 notes, the underlying capacity is $800 million. Our ability to utilize this capacity is subject to compliance with the borrowing base that applies variant advance rates to different types of assets. As MFIC continues to reduce its leverage, we expect our liquidity position to improve. This concludes our prepared remarks. Operators, if you have any further questions,

Thank you. If you would like to ask a question, press star one on your keypad. To leave the queue at any time, press star two. Once again, that is star one to ask a question. Our first question is from Aaron Siganovich with Truist Securities. Your line is open.

Thanks. I guess, you know, as we're looking at had these results and you're kind of, I guess, seeking to deliver and you worked through your buybacks. How does this impact, I guess, your ability to continue to be relevant? I know you have other funds, but maybe just talk a little about some of the dynamics of how you think about this Thanks for the question.

When we look at, I think this is one of the very compelling features of MSIC in the context of our broader middle market franchise mid-cap. in that we are roughly $3 billion of a $50 billion business. and so our participation or non-participation in a loan that's originated by mid-cap does not ultimately affect our ability to provide that solution to that company or to that particular sponsor and as such in the current environment as you alluded to and we mentioned in our fair remarks where we are not participating in new transactions Our METAP franchise and our broader sponsor coverage effort and frankly our broader direct lending effort is not in any way compromised by our non-BIRT participation. And so in that regard, we do benefit from being a relatively small piece of much bigger business.

What are you targeting from a leverage standpoint going forward?

Yeah, sure. So the bottom end of our guidance, so in the low 1.4s. Okay.

So not a whole, not a huge decline, just a modest decline, and you expect to essentially and many more.

We look out, notwithstanding a relatively tepid M&A environment, all things considered, you know, the quantum of companies that we see that are either in process or soon to be in process and the probability way we feel good about our abilities. to get leveraged down, obviously subject to market conditions. But as it relates to what we'll do at that time, it will be evaluated based on market conditions at that time and successful completion of the leveraging.

Thank you for your question. Our next question is from Robert Dodd with Raymond James. Please go ahead.

Hi guys. Obviously there have been a lot of press reports about Strategic Alternatives being reviewed for MFIC. You didn't have any comment about that in your prepared remarks, but can you either give us any comment on that or confirm or deny whether such a review is being undertaken by the board? Yes.

Thanks, Robert.

And as you would probably imagine, as a matter of policy, we do not comment on third-party reporting or rumors in the market. That said, our focus remains and always has on maximizing value for stockholders, a principle that informs every decision we make, and we believe that our buyback Frankly, it's very much in that spirit. Any required disclosures would be made through the appropriate means if and when required, but as I said before, unfortunately, we did not have a comment on that.

Got it. Thank you. On to the mob counts. The number of non-recruits actually went down this quarter, but some of the markdowns, like I think Constant Scientific is not on non-recruit currently, unless I'm incorrect there. I mean, you said, you know, EBITDA pressure, rising leverage, I mean... What's the probability or your thoughts on whether some of these issue credits this quarter could migrate to non-accrual status over the next couple of quarters if they're undergoing obviously EBITDA pressure and leverage going the wrong way?

Thanks, Robert. When we look at the companies in the basket that we're watching very closely and that are having leverage pressure, there's always a number of things going on. We're having conversations with the company. We're having conversations with the sponsor. We're having conversations with other lenders. In some cases, there are businesses that are looking to divest subsidiaries or divisions, which can result in deleveraging. There are situations where the sponsor is considering putting equity in. There are situations where the lender group is willing to put in additional funds or make other concessions to free up cash flow. and so when we look at the basket of those I think if you probability weight that you will have some of those that are resolved super satisfactorily and then you'll have some of those where they continue to be challenged and we'll evaluate quarter by quarter whether we think there's a reasonable prospect of

I would also call attention to the fact that many of these names or many of the names in this bucket that we're watching closely perhaps not surprisingly are from the 2020-2021 vintage capital structure rules that were done in a different industry environment and certainly the The most recent slight pickup in rates and perhaps a prospect for higher for longer or even risk to the upside in terms of rates could challenge the cash flow prospects. But as Ted mentioned, You know, not to obfuscate or dodge the question, there are a lot of factors that go into evaluating each and every one of those decisions, and it's hard to say prospectively how the quantum of those dynamics, you know, filters out in this system that's ultimately in it.

If I can, one more, not related to any of that. You responded to the earlier question. I mean, you sounded more optimistic about the ability to deliver an active market. I mean, essentially all your competitors are saying the same thing. The M&A pipeline is building. We expect it to be... Thank you for joining us.

Look, I think as you're alluding to, a little humility is probably for all market participants on the sanguine prognostications on a pickup in M&A. So with that as a caveat, the repayment activity was actually relatively healthy in the particular quarter against a rather tepid M&A environment. and, you know, importantly, when we are making that judgment, Robert, you know, we are probability waiting, right? We're not saying everything in the process is going to get done. We're saying, you know, the quantum of either revise. In certain cases, you have a BSL market that's not WhiteHot, but is receptive in getting things done, and so there's opportunities for certain of our borrowers to graduate, if you will, as well as also the quantum of sale processes, some of which, as you will probably be well aware, have been deferred. This bid asked everyone hoping that rates would come down, and it seems that another The factor emerges that maybe pushes it along, and obviously many of these holdings within private equity firms are getting pretty long in the suits, but ultimately it is informed by a probability weighting and a strong quantum of things that are in process or soon to be in process or need to be in process. to inform that. And the market caveat that it is subject to market conditions and then I think as your question implied, it's necessary a little bit of humility because we've all thought that the M&A would come streaming back for many, many quarters and frankly years at this point.

Got it. Thank you.

Thank you for your question. Our next question is from Finian O'Shea, Wells Fargo Securities. Please go ahead.

Hey everyone, good morning. Just picking up on some of this dialogue and I appreciate the color you gave on leverage and buybacks and understanding that a lot of it relates to future judgment calls. But zeroing in on the leverage dynamic, like As you contemplate buybacks versus new origination on the go forward, why leave leverage so high given that might be a factor that builds on the discount? And then assuming it goes down the path of continued buybacks, Does that 140 sort of leverage frame go down as, you know, a smaller BDC might have less tolerance for high leverage?

Yeah, thanks for the question, Sam. And it's certainly a subject that we debate and think critically about within the management teams here. And your points are well taken in terms of Even at the lower end of our range, it's a high leverage level. I think when we look at it right now, we are very much focused on getting to the 1.4 and reevaluating. And as we evaluate there, it will, to state the obvious, and again, not to dodge the question, but it will be a factor of where we are trading, what the forward payment pipeline looks like. and then importantly also which we haven't talked about for fairly obvious reasons and that we are not deploying right now is that when we look at the market we did see some widening you know post Iran hostilities some of which particularly in the middle market has been given back and so you know all things being equal that doesn't scream to us right now as a Overlead Compelling Lead Deployment Opportunity. And I offer that up as another factor that will go in to make that decision. But to answer your question specifically, Our focus is right now on getting to the lower end of the range, but we take your points and know that we need to debate that as a management team as well.

Appreciate that. And a follow-up on the picture of spillover... If you can give a, I know it's probably going to be complicated by equity positions, Merck's, et cetera, and can probably move around, but can you sort of outline that for us? Like, what's the degree? Thank you for the question. Approximately as of mid-2020,

just over $16 million as we're targeting through to year end. Obviously, as you mentioned, you know, the impacts of tax around Merck's, some equity positions, some other challenging points, you know, we're targeting potentially up to $100 million subject to, sorry, $1 million subject to, you know, the tax invocations there.

Thank you for your question. Once again, if you would like to ask a question, please press star and 1 on your telephone keypad now.

At this time, there are no further questions in the queue. I will turn the meeting back to management.

Thank you, operator. Thank you, everyone, for listening to today's call on behalf of the entire team. We thank you for your time today. Please feel free to reach out to any of us if you have any additional questions. Please have a nice day.

Thank you. This brings us to the end of today's meeting. We appreciate your time and participation.